4//SEC Filing
MANHATTAN PHARMACEUTICALS INC 4
Accession 0001179110-05-008138
$TGTXCIK 0001001316operating
Filed
Apr 25, 8:00 PM ET
Accepted
Apr 26, 11:08 AM ET
Size
9.1 KB
Accession
0001179110-05-008138
Insider Transaction Report
Form 4
GIMBERT JOAN PONS
Director
Transactions
- Award
Director Stock Option
2005-01-11+25,000→ 25,000 totalExercise: $1.00Exp: 2015-01-11→ Common Stock (25,000 underlying) - Award
Option
2004-01-24+75,000→ 75,000 totalExercise: $1.65Exp: 2014-01-27→ Common Stock (75,000 underlying)
Holdings
- 3,957,037(indirect: By Oleoyl-Estrone Developments SL)
Common Stock
Footnotes (4)
- [F1]The Reporting Person is the chief executive officer of Oleoyl-Estrone Developments SL, a company of unlimited duration registered in the Registro Mercantil of Carcelona ("OED"). The Reporting Person disclaims beneficial Ownership of the shares owned by OED.
- [F2]25,000 shares have vested. 25,000 shares vest, if at all, on 1/28/05 and 1/28/06, respectively.
- [F3]Under the 2003 Stock Option Plan.
- [F4]8,334 shares vest on 1/11/05, 8,333 shares vest on each of 1/11/06 and 1/11/07.
Documents
Issuer
MANHATTAN PHARMACEUTICALS INC
CIK 0001001316
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001001316
Filing Metadata
- Form type
- 4
- Filed
- Apr 25, 8:00 PM ET
- Accepted
- Apr 26, 11:08 AM ET
- Size
- 9.1 KB